Summit Therapeutics hits possible snag on lung cancer drug seen as blockbuster
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
RFK Jr.’s CDC reform plan is similar to secret Susan Monarez memo
WASHINGTON — In the days after health secretary Robert F. Kennedy Jr. pushed out the director of the…
Pfizer defends Covid vaccine effectiveness in response to Trump
Pfizer CEO Albert Bourla on Wednesday defended the development of Covid vaccinations, including Pfizer’s own, suggesting that they…
House bill on HHS budget: NIH funding maintained, deep CDC cuts
WASHINGTON — House appropriators advanced legislation on Tuesday that is a mixed bag for researchers. While the Republican…
Viking Therapeutics oral weight loss drug hits mark in mid-stage trial
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine,…
Kennedy’s mRNA vaccine cancellations sharply criticized by experts
In a sign of the mRNA field’s recent dynamism, the Alliance for mRNA Medicines doubled its size to…
Eli Lilly’s much-anticipated obesity pill falls short of Wegovy
Eli Lilly’s investigational obesity pill led to less weight loss in a late-stage trial than the reductions seen…
Trump demands that pharma companies lower drug prices
President Trump escalated his demands that pharma companies lower U.S. drug prices in line with what other countries…
Senate committee rejects NIH cuts, boosts budget by $400 million
WASHINGTON — Senators from both parties endorsed a $400 million increase to the budget of the National Institutes…
White House blocks NIH from awarding any research grants
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
NIH is shrinking the number of research grants it funds
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…